Investors are Betting Against Sangamo Biosciences, Inc. (SGMO), Should You? - Tale of the Tape

By
A A A

Many investors appear to be quite bearish on Sangamo Biosciences, Inc. ( SGMO ), especially if you look at the percentage of the float that is sold short for this stock. Currently, 20.92% of the float is sold short, suggesting an extreme level of bearishness for SGMO .

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2(Buy) on SGMO, so we clearly don't believe in the negativity surrounding this firm, and are instead looking for shares of SGMO to move higher in the weeks ahead.



SANGAMO BIOSCI (SGMO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: SGMO

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

How to Fire Your Adviser
How to Fire Your Adviser            

Stocks

Referenced

100%

Most Active by Volume

75,750,465
  • $16.77 ▲ 0.36%
59,791,764
  • $101.58 ▲ 0.71%
38,720,622
  • $42.59 ▼ 0.28%
37,416,417
  • $46.52 ▼ 0.51%
35,101,793
  • $16.28 ▲ 0.74%
34,987,975
  • $99.53 ▲ 0.15%
33,760,830
  • $3.63 ▲ 0.69%
32,148,671
  • $17.61 ▲ 0.57%
As of 9/17/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com